Jiangzhong Pharmaceutical Co Ltd (SHG:600750) — Market Cap & Net Worth
Market Cap & Net Worth: Jiangzhong Pharmaceutical Co Ltd (600750)
Jiangzhong Pharmaceutical Co Ltd (SHG:600750) has a market capitalization of $2.08 Billion (CN¥14.19 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #6095 globally and #1179 in its home market, demonstrating a -0.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangzhong Pharmaceutical Co Ltd's stock price CN¥22.32 by its total outstanding shares 635588289 (635.59 Million). Also see Jiangzhong Pharmaceutical Co Ltd asset portfolio for a full breakdown of the balance sheet.
Jiangzhong Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Jiangzhong Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $1.22 Billion to $2.08 Billion (3.51% CAGR). Also see 600750 operating cash flow for how efficiently the company converts equity into cash flow.
Jiangzhong Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangzhong Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 600750 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.51x
Jiangzhong Pharmaceutical Co Ltd's market cap is 0.51 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.38x
Jiangzhong Pharmaceutical Co Ltd's market cap is 2.38 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.08 Billion | $1.55 Billion | $379.76 Million | 0.70x | 2.84x |
| 2017 | $903.34 Million | $1.75 Billion | $417.80 Million | 0.52x | 2.16x |
| 2018 | $861.76 Million | $1.76 Billion | $470.25 Million | 0.49x | 1.83x |
| 2019 | $819.30 Million | $2.45 Billion | $463.60 Million | 0.33x | 1.77x |
| 2020 | $854.48 Million | $2.44 Billion | $473.74 Million | 0.35x | 1.80x |
| 2021 | $1.21 Billion | $2.87 Billion | $505.69 Million | 0.42x | 2.39x |
| 2022 | $1.31 Billion | $3.89 Billion | $598.24 Million | 0.34x | 2.18x |
| 2023 | $1.94 Billion | $4.55 Billion | $718.67 Million | 0.43x | 2.70x |
| 2024 | $2.11 Billion | $4.44 Billion | $788.19 Million | 0.48x | 2.68x |
| 2025 | $2.15 Billion | $4.22 Billion | $906.12 Million | 0.51x | 2.38x |
Competitor Companies of 600750 by Market Capitalization
Companies near Jiangzhong Pharmaceutical Co Ltd in the global market cap rankings as of September 24, 2026. Review how tangible is Jiangzhong Pharmaceutical Co Ltd's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Jiangzhong Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
Jiangzhong Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Jiangzhong Pharmaceutical Co Ltd's market cap moved from $1.22 Billion to $ 2.08 Billion, with a yearly change of 3.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.08 Billion | -3.67% |
| 2025 | CN¥2.15 Billion | +2.07% |
| 2024 | CN¥2.11 Billion | +8.72% |
| 2023 | CN¥1.94 Billion | +48.68% |
| 2022 | CN¥1.31 Billion | +7.99% |
| 2021 | CN¥1.21 Billion | +41.55% |
| 2020 | CN¥854.48 Million | +4.29% |
| 2019 | CN¥819.30 Million | -4.93% |
| 2018 | CN¥861.76 Million | -4.60% |
| 2017 | CN¥903.34 Million | -16.37% |
| 2016 | CN¥1.08 Billion | -11.50% |
| 2015 | CN¥1.22 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Jiangzhong Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.08 Billion USD |
| MoneyControl | $2.08 Billion USD |
| MarketWatch | $2.08 Billion USD |
| marketcap.company | $2.08 Billion USD |
| Reuters | $2.08 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiangzhong Pharmaceutical Co Ltd
China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsu… Read more